Pathogenicity of Mediator Complex Subunit 27 (MED27) in a Neurodevelopmental Disorder with Cerebellar Atrophy

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• Neurodevelopmental disorders (NDDs) present significant challenges, with a vast majority lacking effective treatments.
• Understanding pathogenic mechanisms is crucial for developing precision gene therapies for NDDs.
• A specific autosomal recessive NDD linked to MED27 gene variants has been identified, primarily affecting the cerebellum.

Purpose of the Study:

• To investigate the pathogenic mechanisms of MED27 variants in neurodevelopmental disorders.
• To develop and utilize preclinical models that recapitulate patient phenotypes.
• To elucidate the molecular consequences of MED27 dysfunction on gene regulation and cerebellar development.

Main Methods:

• Generation of in vitro stem cells with patient-specific MED27 variants.
• Creation of in vivo mouse models with Med27 loss-of-function.
• Molecular analyses including chromatin occupancy, interaction studies, and transcriptomic profiling (spatial transcriptomics).

Main Results:

• Preclinical models successfully replicated key patient phenotypes like cerebellar atrophy and motor deficits.
• Mutant MED27 destabilizes the Mediator complex, affecting its chromatin binding and interactions.
• Dysregulation of downstream gene targets, including key transcription factors for neurogenesis, was identified.

Conclusions:

• A partial loss-of-function mechanism for MED27-associated NDDs has been elucidated.
• The study highlights the cerebellum's vulnerability to MED27 dysfunction.
• This work provides a framework for studying NDDs linked to Mediator complex subunit variants.